Neale Cohen

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Benefits for Type 2 Diabetes of Interrupting Prolonged Sitting With Brief Bouts of Light Walking or Simple Resistance Activities

Paddy C. Dempsey, Robyn N. Larsen, Parneet Sethi et al. · Diabetes Care · 2016 · 403 citations · Full text

Medicine, Kinesiology, Nutritional Sciences +17

Interrupting prolonged sitting with brief bouts of light walking or simple resistance activities reduces resting blood pressure and plasma noradrenaline in type 2 diabetes

Paddy C. Dempsey, Julian W. Sacre, Robyn N. Larsen et al. · Journal of Hypertension · 2016 · 175 citations · Full text

Medicine, Nutritional Sciences, Physiology +16

Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial

Sybil A. McAuley, Melissa H. Lee, Barbora Paldus et al. · Diabetes Care · 2020 · 156 citations · Full text

Medicine, Endocrinology, Internal Medicine +17